01
Why the name is tempting
“Delta sleep-inducing” sounds like a product. The review outcome is the opposite of a product.
- ·Sleep research history
- ·Not recommended for the bulks list
- ·Not orderable
RE GEN RX · peptides / DSIP (Emideltide)
No lawful pathway
DSIP (Emideltide)
Delta sleep-inducing peptide — PCAC reviewed it in July 2026 and did not recommend it.
Oswego, Illinois · 74 W. Washington St · serving the Fox Valley. A licensed Illinois clinician still decides. Compounded medications are not FDA-approved.
Legal status reviewed July 2026 · Not continuous
What is DSIP (Emideltide)?
The molecule, in plain language.
DSIP (emideltide) is a peptide historically studied for sleep architecture. In July 2026 PCAC reviewed it for the 503A bulks list and did not recommend it. RE GEN will not compound it.
How people usually take it. Not orderable. Not a nightly peptide we can send.
What people are actually trying to solve.
Interest is not a result. We keep the research language and skip the miracle.
02
Different from the six that were recommended
BPC-157, TB-500, KPV, MOTS-c, Semax, and Epitalon were recommended. DSIP was not. None of those six are orderable yet either.
- ·Recommendation still is not listing
- ·Non-recommendation is a hard no today
- ·Do not gray-market a sleep peptide
03
What we can talk about
Sleep and stress goals can still go through a visit. We will not pretend DSIP is the tool.
- ·Consult
- ·NAD+ when appropriate
- ·No DSIP workaround
What the evidence actually is — and what it isn’t.
A note on honesty: we will tell you what the literature supports and what it does not. Animal data is not a human guarantee. Anecdotes are not trials.
Animal research
DSIP has older preclinical sleep literature.
- ·Not a modern 503A basis
- ·PCAC did not recommend listing
- ·Not orderable
Human research
Human evidence is limited. The advisory committee’s non-recommendation is the operational fact for this page.
- ·Not orderable
- ·No sleep-score promise in any case
- ·Do not buy research DSIP
Legal basis at RE GEN · July 2026
We will not compound this today.
Reviewed by PCAC in July 2026 and not recommended. No lawful §503A pathway. We will not compound DSIP / emideltide.
We will not compound this. Ask us what is carried instead.
Common questions
Peptide education for Illinois patients at RE GEN in Oswego — not a substitute for a visit.
What is DSIP?
Delta sleep-inducing peptide (emideltide). PCAC did not recommend it for the 503A bulks list in July 2026. Not orderable.
Is DSIP FDA-approved?
DSIP is not FDA-approved, and RE GEN does not have a lawful §503A pathway to request it as a compounded medication today. A committee vote is not approval.
Can I get DSIP at RE GEN in Oswego?
You can start a visit to talk about your goal. We will not compound DSIP today. We will show you what is carried instead — and we will say no rather than gray-market a vial.
Can I take it as needed, not nightly?
We cannot compound it at all — continuous or as-needed. The legal answer is no.
Do you promise results?
No. Educational pages explain why people ask and what the research landscape looks like. Individual response varies. Compounded medications are not FDA-approved, and a request is not a guaranteed prescription.
Related on this menu
Illinois practice · licensed 503A compounding
We will tell you no — and show you what is carried instead.
Hello Gorgeous PC · 74 W. Washington St, Oswego, IL
RE GEN desk 630-636-6193
Start a visit, a licensed Illinois clinician reviews, then you pay the invoice. If they don't prescribe, we refund.